Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Here's hoping that our attempts at dosing do not take too much time to sort out- but, as discussed, Aprea just took 2 years on such a project. I really wish CTIX would proceed with some extra dosing of many solid tumors- but I have ranted about this for a while. They could gain such valuable info, that could inform p2 ovarian dosing certainly.

There has been no mention of K monotherapy in the last couple of ovarian p2 pr's, and I wonder if it has been scrapped. If so, that does not bother me as I see our future in combo anyway.

I will reread results page- I could only see the CA125 results for 2 patients as of the October results but they may have announced more